The First Instance Decision:
The French Athletics Federation (FFA) decided on 19 August 2015 to impose a 2 year period of ineligibility on the Athlete M64 after he tested positive for the prohibited substance Triamcinolone.
Hereafter the French Anti-Doping Agency (AFLD) appealed the FFA First Instance Decision.
The Athlete:
M64 stated that the violation was not intentional and explained with medical evidence that he had used a prescribed ointment as treatment for his condition he suffered that contained Triamcinolone Acétonide.
The AFLD:
The French Anti-Doping Agency accepts the medical evidence and deems that the Athlete failed to produce this medical evidence in the First Instance FFA disciplinary proceedings.
The Decision:
The AFLD decides on 2 December 2015 to confirm the FFA decision of 19 August 2015 and also to extend the sanction imposed on the Athlete M64 to other French Sports Federations.
